
P31 Abatacept increases the proportion of patients who remain free from structural damage progression through 5 years in methotrexate inadequate responders with RA
Gregory Macaraeg, K Genant, C Peterfy, R Westhovens, JC Becker, G Vratsanos, X Zhou, J KremerVolume:
4
Année:
2009
Langue:
english
DOI:
10.1016/s0973-3698(09)60049-2
Fichier:
PDF, 64 KB
english, 2009